BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31550190)

  • 21. Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States.
    Bajpai S; Wong-Jacobson S; Liu D; Mitchell B; Haynes G; Syring K; Ali AK; Chinthammit C
    J Manag Care Spec Pharm; 2021 Mar; 27(3):385-391. PubMed ID: 33645242
    [No Abstract]   [Full Text] [Related]  

  • 22. Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care.
    Bieszk N; Grabner M; Wei W; Barron J; Quimbo R; Yan T; Biel B; Chu JW
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1160-1168. PubMed ID: 29083969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States.
    Joish VN; Zhou FL; Preblick R; Lin D; Deshpande M; Verma S; Davies MJ; Paranjape S; Pettus J
    J Manag Care Spec Pharm; 2020 Mar; 26(3):311-318. PubMed ID: 32105172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J; Lee WC; Aagren M; Christensen T
    J Manag Care Pharm; 2012; 18(1):21-32. PubMed ID: 22235952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database.
    Eby EL; Bajpai S; Faries DE; Haynes VS; Lage MJ
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1081-1089. PubMed ID: 32857656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
    Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
    Buysman EK; Liu F; Hammer M; Langer J
    Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.
    Thayer S; Wei W; Buysman E; Brekke L; Crown W; Grabner M; Raparla S; Quimbo R; Cziraky MJ; Hu W; Cuddihy R
    Adv Ther; 2013 Dec; 30(12):1128-40. PubMed ID: 24293131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Early Response to GLP-1 RA Therapy on Long-Term Adherence and Persistence Among Type 2 Diabetes Patients in the United States.
    Durden E; Liang M; Fowler R; Panton UH; Mocevic E
    J Manag Care Spec Pharm; 2019 Jun; 25(6):669-680. PubMed ID: 30896359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy.
    Schwab P; Racsa P; Rascati K; Mourer M; Meah Y; Worley K
    J Manag Care Spec Pharm; 2019 Mar; 25(3):332-340. PubMed ID: 30816817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population.
    Lee S; Xie L; Wang Y; Vaidya N; Baser O
    J Manag Care Spec Pharm; 2018 Jul; 24(7):654-663. PubMed ID: 29952710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes Mellitus.
    Chen J; Nair R; Siadaty M; Brown K; Meah Y; Taylor AD; He X; Fan L
    J Manag Care Spec Pharm; 2020 Jul; 26(7):839-847. PubMed ID: 32584684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benchmarking Insulin Treatment Persistence Among Patients with Type 2 Diabetes Across Different U.S. Payer Segments.
    Wei W; Jiang J; Lou Y; Ganguli S; Matusik MS
    J Manag Care Spec Pharm; 2017 Mar; 23(3):278-290. PubMed ID: 28230445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis.
    Sutton D; Higdon CD; Nikkel C; Hilsinger KA
    Adv Ther; 2018 May; 35(5):631-643. PubMed ID: 29748915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID.
    Baser O; Wei W; Baser E; Xie L
    J Med Econ; 2011; 14(6):673-80. PubMed ID: 21892858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.